Multidrug-resistant bacteria among patients treated in foreign hospitals: Management considerations during medical repatriation

Journal of Travel Medicine

Volumn 20, Issue 1, 2013, Pages 22-28

  Josseaume, Julien ^a   Verner, Laurent ^a   Brady, William J ^b,c,d   Duchateau, François Xavier ^a  

^a Medical Department   (France)

^b Allianz Global Assistance   (United States)

^c Medical Department   (Canada)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AFRICA SOUTH OF THE SAHARA; AIR MEDICAL TRANSPORT; ASIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM; BURN; EMERGENCY CARE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EUROPE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; FRANCE; GASTROENTERITIS; HEART ARREST; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INJURY; INTENSIVE CARE UNIT; LEG ISCHEMIA; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT BACTERIA; NORTH AFRICA; PATIENT TRANSPORT; REVIEW; SEPTIC SHOCK; TRAVEL;

ADULT; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CHILD; CRITICAL PATHWAYS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; INTERNATIONALITY; LENGTH OF STAY; MALE; PATIENT TRANSFER; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSFER AGREEMENT;

EID: 84871613891     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00668.x     Document Type: Review

References (22)

1. Lepelletier D, Andremont A, Grandbastien B,; National Working Group. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Travel Med 2011; 18: 344-351.
2. Woodford N,. Unwanted souvenirs: travel and multi-resistant bacteria. J Travel Med 2011; 18: 297-298.
3. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL,. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 2011; 53: 49-56.
4. Fischer D, Veldman A, Schafer V, Diefenbach M,. Bacterial colonization of patients undergoing international air transport: a prospective epidemiologic study. J Travel Med 2004; 11: 44-48.
5. Kaiser AM, Schultsz C, Kruithof GJ, et al. Carriage of resistant microorganisms in repatriates from foreign hospitals to the Netherlands. Clin Microbiol Infect 2004; 10: 972-979.
6. Birgand G, Blanckaert K, Carbonne A, et al. Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009. Euro Surveill 2010; 15: 19597.
7. Naas T, Nordmann P, Vedel G, Poyart C,. Plasmid mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49: 4423-4424.
8. Carbonne A, Thiolet JM, Fournier S, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010; 15: 19734.
9. Vaux S, Carbonne A, Thiolet JM, et al. Emergence of carbapenemase- producing Enterobacteriaceae in France, 2004 to 2011. Euro Surveill 2011; 16: 19880.
10. Haut Conseil de la Santé publique. Commission spé cialisée Sécurité des patients: infections nosocomiales et autres évènements indésirables liés aux soins et aux pratiques. Recommandations pour le dépistage du portage digestif des bactéries commensales multi-résistantes aux antibiotiques importées en France à l'occasion du rapatriement de patients en provenance de l'étranger et maatrise de leur diffusion. 2010. Available at: http://www.hcsp.fr/docspdf/avisrapports/hcspr20100518-bmrimportees.pdf. (Accessed 2012 Sep 18).
11. Duchateau FX, Verner L, Cha O, Corder B,. Decision criteria of immediate aeromedical evacuation. J Travel Med 2009; 16: 391-394.
12. Livermore DM,. Has the era of untreatable infection arrived? J Antimicrob Chemother 2009; 64: 29-36.
13. Poirel L, Pitout JD, Nordmann P,. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-512.
14. Nordmann P, Cuzon G, Naas T,. The real threat of carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-236.
15. Teichman PG, Donchin Y, Kot RJ,. International aeromedical evacuation. N Engl J Med 2007; 356: 262-270.
16. Duchateau FX, Verner L,. K-plan for patient repatriation after mass casualty events abroad. Air Med J 2012; 31: 92-94.
17. Circulaire DGS-DUS-CORRUS-N°2012-188 du 9 mai 2012-relative aux rapatriements sanitaires. Available at: http://circulaires.legifrance.gouv.fr/ pdf/2012/05/cir-35292.pdf (Accessed 2012 Sep 18)
18. Carrera PM, Bridges JF,. Globalization and healthcare: understanding health and medical tourism. Expert Rev Pharmacoecon Outcomes Res 2006; 6: 447-454.
19. Reed CM,. Medical tourism. Med Clin North Am 2008; 92: 1433-1446.
20. Lunt N, Carrera P,. Medical tourism: assessing the evidence on treatment abroad. Maturitas 2010; 66: 27-32.
21. American College of Surgeons. Statement on medical and surgical tourism. Bull Am Coll Surg 2009; 94: 26-27.
22. Hopkins L, Labonté R, Runnels V, Packer C,. Medical tourism today: what is the state of existing knowledge? J Public Health Policy 2010; 31: 185-198.